GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Specialty Natural Products PCL (BKK:SNPS-F) » Definitions » Debt-to-EBITDA

Specialty Natural Products PCL (BKK:SNPS-F) Debt-to-EBITDA : 0.06 (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Specialty Natural Products PCL Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Specialty Natural Products PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ฿4.9 Mil. Specialty Natural Products PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ฿2.2 Mil. Specialty Natural Products PCL's annualized EBITDA for the quarter that ended in Mar. 2025 was ฿125.6 Mil. Specialty Natural Products PCL's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2025 was 0.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Specialty Natural Products PCL's Debt-to-EBITDA or its related term are showing as below:

BKK:SNPS-F' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.04   Med: 1.94   Max: 1.96
Current: 0.06

During the past 3 years, the highest Debt-to-EBITDA Ratio of Specialty Natural Products PCL was 1.96. The lowest was 0.04. And the median was 1.94.

BKK:SNPS-F's Debt-to-EBITDA is ranked better than
94.21% of 1520 companies
in the Consumer Packaged Goods industry
Industry Median: 2.21 vs BKK:SNPS-F: 0.06

Specialty Natural Products PCL Debt-to-EBITDA Historical Data

The historical data trend for Specialty Natural Products PCL's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Specialty Natural Products PCL Debt-to-EBITDA Chart

Specialty Natural Products PCL Annual Data
Trend Dec22 Dec23 Dec24
Debt-to-EBITDA
1.94 1.96 0.04

Specialty Natural Products PCL Quarterly Data
Dec22 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Debt-to-EBITDA Get a 7-Day Free Trial -2.06 - 1.18 0.02 0.06

Competitive Comparison of Specialty Natural Products PCL's Debt-to-EBITDA

For the Household & Personal Products subindustry, Specialty Natural Products PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Specialty Natural Products PCL's Debt-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Specialty Natural Products PCL's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Specialty Natural Products PCL's Debt-to-EBITDA falls into.


;
;

Specialty Natural Products PCL Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Specialty Natural Products PCL's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.99 + 2.737) / 122.095
=0.04

Specialty Natural Products PCL's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.895 + 2.232) / 125.616
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2025) EBITDA data.


Specialty Natural Products PCL  (BKK:SNPS-F) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Specialty Natural Products PCL Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Specialty Natural Products PCL's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Specialty Natural Products PCL Business Description

Traded in Other Exchanges
Address
700/364 Moo 6, Amata Nakorn Industrial Estate, Nong Mai Daeng, Mueang Chon buri, Chon buri, THA, 20000
Specialty Natural Products PCL produces and extracts Thai herbs that meet world-class standards, which are used in the medical field, weight loss supplements, body care supplements, food and cosmetic businesses. The company is a processor of nutraceuticals, functional food, beverage, cosmetic, and body care ingredients. Its herbal active pharmaceutical ingredients include Senna Extract Liquid and Andrographis Paniculata Extract Powder. The Group generates revenue from external customers from both domestic and overseas. Key revenue is generated from the domestic costumers.

Specialty Natural Products PCL Headlines

No Headlines